Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

NOVO-PROPOXYN COMPOUND CAP DIN 00277118

Status: Cancelled Post Market
Holder: NOVOPHARM LIMITED
Molecule: DEXTROPROPOXYPHENE HYDROCHLORIDE

Health Canada record

Active ingredient(s)DEXTROPROPOXYPHENE HYDROCHLORIDE 65 MG; ACETYLSALICYLIC ACID 375 MG; CAFFEINE 30 MG
Dosage formCapsule
RouteOral
ScheduleNARCOTICS (CDSA I)
ClassHuman
ATCN02AC54 DEXTROPROPOXYPHENE, COMB EXCL PSYCHOLEPT
Original market date31-Dec-1973
Current status date10-Aug-2005
SourceHealth Canada DPD

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing DEXTROPROPOXYPHENE HYDROCHLORIDE

DINProductCompanyFormStrengthStatus
00010081642 TABPENDOPHARM DIVISION OF PHARMASCIENCE INCTabletDEXTROPROPOXYPHENE HYDROCHLORIDE 65 MGCancelled Post Market
00108146692 TABMERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO.TabletDEXTROPROPOXYPHENE HYDROCHLORIDE 65 MG; ACETYLSALICYLIC ACID 375 MG; CAFFEINE 30 MGCancelled Post Market
02234509692 TABLETLIOH INC.TabletDEXTROPROPOXYPHENE HYDROCHLORIDE 65 MG; ACETYLSALICYLIC ACID 375 MG; CAFFEINE 30 MGCancelled Post Market
00151351NOVO-PROPOXYN CAP 65MGNOVOPHARM LIMITEDCapsuleDEXTROPROPOXYPHENE HYDROCHLORIDE 65 MGCancelled Post Market

International API supply for DEXTROPROPOXYPHENE HYDROCHLORIDE

0 valid EDQM Certificates of Suitability from 0 holders.

Request a quote for NOVO-PROPOXYN COMPOUND CAP

How to read a Canadian DIN record